Aerpio Pharmaceuticals
Cincinnati
About Aerpio Pharmaceuticals
Aerpio Pharmaceuticals is a new, clinical-stage biotechnology company focused on the development of novel small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Aerpio was created in a spin-out transaction from Akebia Therapeutics to enable more rapid development of its exciting compounds. It is managed by the same successful team from Akebia, employing a similar outsourced approach to pharmaceutical development. Aerpio Pharmaceuticals was founded in 2011 and is based in Cincinnati, Ohio, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $107.5M
- Funding stage: IPO
- Last round: Series Unknown (Mar 2017)
- Ticker: nasdaq:ARPO
- Website: aerpio.com
- Phone: (513) 985-1924
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aerpio-pharmaceuticals-194451 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.